Home  /  Resource Library  /  Chimeric antigen receptor T-cell therapy in diffuse large B-cell lymphoma: Evaluating axicabtagene ciloleucel in the ZUMA-7 trial

Chimeric antigen receptor T-cell therapy in diffuse large B-cell lymphoma: Evaluating axicabtagene ciloleucel in the ZUMA-7 trial

Results of a study investigating CAR-T Axicabtagene ciloleucel for treatment of relapsed large b-cell lymphomas.